ID

38450

Descrizione

Sym004 in Subjects With Squamous Cell Carcinoma of Head and Neck (SCCHN) Failing Anti-Epidermal Growth Factor Receptor (Anti-EGFR) Based Therapy; ODM derived from: https://clinicaltrials.gov/show/NCT01417936

collegamento

https://clinicaltrials.gov/show/NCT01417936

Keywords

versioni (1)
  1. 18/10/19 18/10/19 -
Titolare del copyright

See clinicaltrials.gov

Caricato su

18 ottobre 2019

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Carcinoma, Squamous Cell of Head and Neck NCT01417936

Inglese

Eligibility Carcinoma, Squamous Cell of Head and Neck NCT01417936

1 moduli  
Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically confirmed diagnosis initially or at relapse of scchn of the oral cavity, oropharynx, hypopharynx or larynx
Descrizione

Squamous cell carcinoma of the head and neck Initially | Recurrent Head and Neck Squamous Cell Carcinoma | Squamous cell carcinoma of mouth | Squamous cell carcinoma of oropharynx | Squamous cell carcinoma of the hypopharynx | Laryngeal Squamous Cell Carcinoma | Squamous cell carcinoma of the oral cavity recurrent | Oropharyngeal squamous cell carcinoma recurrent | Squamous cell carcinoma of the hypopharynx recurrent | Laryngeal squamous cell carcinoma recurrent

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1168401
UMLS CUI [1,2]
C0205265
UMLS CUI [2]
C4524839
UMLS CUI [3]
C0585362
UMLS CUI [4]
C0280313
UMLS CUI [5]
C0280321
UMLS CUI [6]
C0280324
UMLS CUI [7]
C0861556
UMLS CUI [8]
C0280376
UMLS CUI [9]
C0280392
UMLS CUI [10]
C0280401
recurrent and/or metastatic scchn not amenable to curative treatment with surgery and/or (chemo)radiation
Descrizione

Recurrent Head and Neck Squamous Cell Carcinoma Inappropriate Curative Surgery | HEAD NECK CANCER SQUAMOUS CELL METASTATIC Inappropriate Curative Surgery | Recurrent Head and Neck Squamous Cell Carcinoma Inappropriate Therapeutic radiology procedure Curative | HEAD NECK CANCER SQUAMOUS CELL METASTATIC Inappropriate Therapeutic radiology procedure Curative | Recurrent Head and Neck Squamous Cell Carcinoma Inappropriate Chemoradiotherapy Curative | HEAD NECK CANCER SQUAMOUS CELL METASTATIC Inappropriate Chemoradiotherapy Curative

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C4524839
UMLS CUI [1,2]
C1548788
UMLS CUI [1,3]
C1511562
UMLS CUI [2,1]
C0744620
UMLS CUI [2,2]
C1548788
UMLS CUI [2,3]
C1511562
UMLS CUI [3,1]
C4524839
UMLS CUI [3,2]
C1548788
UMLS CUI [3,3]
C1522449
UMLS CUI [3,4]
C1276305
UMLS CUI [4,1]
C0744620
UMLS CUI [4,2]
C1548788
UMLS CUI [4,3]
C1522449
UMLS CUI [4,4]
C1276305
UMLS CUI [5,1]
C4524839
UMLS CUI [5,2]
C1548788
UMLS CUI [5,3]
C0436307
UMLS CUI [5,4]
C1276305
UMLS CUI [6,1]
C0744620
UMLS CUI [6,2]
C1548788
UMLS CUI [6,3]
C0436307
UMLS CUI [6,4]
C1276305
previous treatment with an anti-egfr monoclonal antibody (mab) in the palliative setting either as monotherapy or in combination with chemotherapy or radiotherapy and showing:
Descrizione

Anti-egfr monoclonal antibody therapy Palliative | Combined Modality Therapy | Chemotherapy | Therapeutic radiology procedure

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C4316122
UMLS CUI [1,2]
C1285530
UMLS CUI [2]
C0009429
UMLS CUI [3]
C0392920
UMLS CUI [4]
C1522449
documented clinical benefit or response for at least 8 weeks (pr, cr or sd) on the anti-egfr mab-based therapy and
Descrizione

Benefit Clinical Anti-egfr monoclonal antibody therapy | Response Anti-egfr monoclonal antibody therapy | Partial response | In complete remission | Stable Disease

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0814225
UMLS CUI [1,2]
C0205210
UMLS CUI [1,3]
C4316122
UMLS CUI [2,1]
C1704632
UMLS CUI [2,2]
C4316122
UMLS CUI [3]
C1521726
UMLS CUI [4]
C0677874
UMLS CUI [5]
C0677946
documented disease progression (verified by computed tomography [ct] scan or magnetic resonance imaging [mri] according to recist (1.1) during or within 12 weeks following the last administration of anti-egfr mab
Descrizione

Disease Progression CT scan | Disease Progression MRI | Status post Anti-egfr monoclonal antibody therapy

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0242656
UMLS CUI [1,2]
C0040405
UMLS CUI [2,1]
C0242656
UMLS CUI [2,2]
C0024485
UMLS CUI [3,1]
C0231290
UMLS CUI [3,2]
C4316122
accessible tumor for biopsy and subject acceptance of repeat tumor biopsies
Descrizione

Neoplasm Amenable Biopsy | Neoplasm Biopsy Repeated

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0027651
UMLS CUI [1,2]
C3900053
UMLS CUI [1,3]
C0005558
UMLS CUI [2,1]
C0027651
UMLS CUI [2,2]
C0005558
UMLS CUI [2,3]
C0205341
other protocol-defined inclusion criteria could apply
Descrizione

Inclusion criteria Study Protocol

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1512693
UMLS CUI [1,2]
C2348563
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
more than 2 lines of prior chemotherapy in the palliative setting
Descrizione

Prior Chemotherapy Palliative Quantity

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1514457
UMLS CUI [1,2]
C1285530
UMLS CUI [1,3]
C1265611
expected survival <12 weeks
Descrizione

Life Expectancy

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0023671
subjects with known brain metastases
Descrizione

Metastatic malignant neoplasm to brain

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0220650
chemotherapy or radiation therapy within 21 days prior to visit 2 at the exception of palliative radiotherapy for bleeding or pain, which is allowed anytime, if not given on target lesions
Descrizione

Chemotherapy Recent | Therapeutic radiology procedure Recent | Exception Therapeutic radiology procedure Palliative Hemorrhage | Exception Therapeutic radiology procedure Palliative Pain

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C0332185
UMLS CUI [2,1]
C1522449
UMLS CUI [2,2]
C0332185
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C1522449
UMLS CUI [3,3]
C1285530
UMLS CUI [3,4]
C0019080
UMLS CUI [4,1]
C1705847
UMLS CUI [4,2]
C1522449
UMLS CUI [4,3]
C1285530
UMLS CUI [4,4]
C0030193
anti-egfr mabs within 14 days prior to visit 2
Descrizione

Anti-egfr monoclonal antibody therapy Recent

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C4316122
UMLS CUI [1,2]
C0332185
major surgery within 4 weeks prior to visit 2 and subjects must have recovered from effects of major surgery
Descrizione

Major surgery | Toxicity Due to Major surgery | Patient recovered

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0679637
UMLS CUI [2,1]
C0600688
UMLS CUI [2,2]
C0678226
UMLS CUI [2,3]
C0679637
UMLS CUI [3]
C1115804
other protocol-defined exclusion criteria could apply
Descrizione

Exclusion Criteria Study Protocol

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0680251
UMLS CUI [1,2]
C2348563
Ritorna all'inizio della pagina

Similar models

Eligibility Carcinoma, Squamous Cell of Head and Neck NCT01417936

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
Squamous cell carcinoma of the head and neck Initially | Recurrent Head and Neck Squamous Cell Carcinoma | Squamous cell carcinoma of mouth | Squamous cell carcinoma of oropharynx | Squamous cell carcinoma of the hypopharynx | Laryngeal Squamous Cell Carcinoma | Squamous cell carcinoma of the oral cavity recurrent | Oropharyngeal squamous cell carcinoma recurrent | Squamous cell carcinoma of the hypopharynx recurrent | Laryngeal squamous cell carcinoma recurrent
Item
histologically confirmed diagnosis initially or at relapse of scchn of the oral cavity, oropharynx, hypopharynx or larynx
boolean
C1168401 (UMLS CUI [1,1])
C0205265 (UMLS CUI [1,2])
C4524839 (UMLS CUI [2])
C0585362 (UMLS CUI [3])
C0280313 (UMLS CUI [4])
C0280321 (UMLS CUI [5])
C0280324 (UMLS CUI [6])
C0861556 (UMLS CUI [7])
C0280376 (UMLS CUI [8])
C0280392 (UMLS CUI [9])
C0280401 (UMLS CUI [10])
Recurrent Head and Neck Squamous Cell Carcinoma Inappropriate Curative Surgery | HEAD NECK CANCER SQUAMOUS CELL METASTATIC Inappropriate Curative Surgery | Recurrent Head and Neck Squamous Cell Carcinoma Inappropriate Therapeutic radiology procedure Curative | HEAD NECK CANCER SQUAMOUS CELL METASTATIC Inappropriate Therapeutic radiology procedure Curative | Recurrent Head and Neck Squamous Cell Carcinoma Inappropriate Chemoradiotherapy Curative | HEAD NECK CANCER SQUAMOUS CELL METASTATIC Inappropriate Chemoradiotherapy Curative
Item
recurrent and/or metastatic scchn not amenable to curative treatment with surgery and/or (chemo)radiation
boolean
C4524839 (UMLS CUI [1,1])
C1548788 (UMLS CUI [1,2])
C1511562 (UMLS CUI [1,3])
C0744620 (UMLS CUI [2,1])
C1548788 (UMLS CUI [2,2])
C1511562 (UMLS CUI [2,3])
C4524839 (UMLS CUI [3,1])
C1548788 (UMLS CUI [3,2])
C1522449 (UMLS CUI [3,3])
C1276305 (UMLS CUI [3,4])
C0744620 (UMLS CUI [4,1])
C1548788 (UMLS CUI [4,2])
C1522449 (UMLS CUI [4,3])
C1276305 (UMLS CUI [4,4])
C4524839 (UMLS CUI [5,1])
C1548788 (UMLS CUI [5,2])
C0436307 (UMLS CUI [5,3])
C1276305 (UMLS CUI [5,4])
C0744620 (UMLS CUI [6,1])
C1548788 (UMLS CUI [6,2])
C0436307 (UMLS CUI [6,3])
C1276305 (UMLS CUI [6,4])
Anti-egfr monoclonal antibody therapy Palliative | Combined Modality Therapy | Chemotherapy | Therapeutic radiology procedure
Item
previous treatment with an anti-egfr monoclonal antibody (mab) in the palliative setting either as monotherapy or in combination with chemotherapy or radiotherapy and showing:
boolean
C4316122 (UMLS CUI [1,1])
C1285530 (UMLS CUI [1,2])
C0009429 (UMLS CUI [2])
C0392920 (UMLS CUI [3])
C1522449 (UMLS CUI [4])
Benefit Clinical Anti-egfr monoclonal antibody therapy | Response Anti-egfr monoclonal antibody therapy | Partial response | In complete remission | Stable Disease
Item
documented clinical benefit or response for at least 8 weeks (pr, cr or sd) on the anti-egfr mab-based therapy and
boolean
C0814225 (UMLS CUI [1,1])
C0205210 (UMLS CUI [1,2])
C4316122 (UMLS CUI [1,3])
C1704632 (UMLS CUI [2,1])
C4316122 (UMLS CUI [2,2])
C1521726 (UMLS CUI [3])
C0677874 (UMLS CUI [4])
C0677946 (UMLS CUI [5])
Disease Progression CT scan | Disease Progression MRI | Status post Anti-egfr monoclonal antibody therapy
Item
documented disease progression (verified by computed tomography [ct] scan or magnetic resonance imaging [mri] according to recist (1.1) during or within 12 weeks following the last administration of anti-egfr mab
boolean
C0242656 (UMLS CUI [1,1])
C0040405 (UMLS CUI [1,2])
C0242656 (UMLS CUI [2,1])
C0024485 (UMLS CUI [2,2])
C0231290 (UMLS CUI [3,1])
C4316122 (UMLS CUI [3,2])
Neoplasm Amenable Biopsy | Neoplasm Biopsy Repeated
Item
accessible tumor for biopsy and subject acceptance of repeat tumor biopsies
boolean
C0027651 (UMLS CUI [1,1])
C3900053 (UMLS CUI [1,2])
C0005558 (UMLS CUI [1,3])
C0027651 (UMLS CUI [2,1])
C0005558 (UMLS CUI [2,2])
C0205341 (UMLS CUI [2,3])
Inclusion criteria Study Protocol
Item
other protocol-defined inclusion criteria could apply
boolean
C1512693 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
Prior Chemotherapy Palliative Quantity
Item
more than 2 lines of prior chemotherapy in the palliative setting
boolean
C1514457 (UMLS CUI [1,1])
C1285530 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
Life Expectancy
Item
expected survival <12 weeks
boolean
C0023671 (UMLS CUI [1])
Metastatic malignant neoplasm to brain
Item
subjects with known brain metastases
boolean
C0220650 (UMLS CUI [1])
Chemotherapy Recent | Therapeutic radiology procedure Recent | Exception Therapeutic radiology procedure Palliative Hemorrhage | Exception Therapeutic radiology procedure Palliative Pain
Item
chemotherapy or radiation therapy within 21 days prior to visit 2 at the exception of palliative radiotherapy for bleeding or pain, which is allowed anytime, if not given on target lesions
boolean
C0392920 (UMLS CUI [1,1])
C0332185 (UMLS CUI [1,2])
C1522449 (UMLS CUI [2,1])
C0332185 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C1522449 (UMLS CUI [3,2])
C1285530 (UMLS CUI [3,3])
C0019080 (UMLS CUI [3,4])
C1705847 (UMLS CUI [4,1])
C1522449 (UMLS CUI [4,2])
C1285530 (UMLS CUI [4,3])
C0030193 (UMLS CUI [4,4])
Anti-egfr monoclonal antibody therapy Recent
Item
anti-egfr mabs within 14 days prior to visit 2
boolean
C4316122 (UMLS CUI [1,1])
C0332185 (UMLS CUI [1,2])
Major surgery | Toxicity Due to Major surgery | Patient recovered
Item
major surgery within 4 weeks prior to visit 2 and subjects must have recovered from effects of major surgery
boolean
C0679637 (UMLS CUI [1])
C0600688 (UMLS CUI [2,1])
C0678226 (UMLS CUI [2,2])
C0679637 (UMLS CUI [2,3])
C1115804 (UMLS CUI [3])
Exclusion Criteria Study Protocol
Item
other protocol-defined exclusion criteria could apply
boolean
C0680251 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial